Investors in Novartis can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the Swiss market. Analysts expect a dividend of 2,93 CHF per share. Thus the dividend yield equals 3,8 percent. The average dividend yield of the pharmaceutical companies is a limited 0,5 percent.
Tomorrow the Swiss Novartis will report its past quarter results. For this year Novartis's revenue will be around 49,55 billion CHF. This is according to the average of the analysts' estimates. This is slightly lower than 2017's revenue of 53,17 billion CHF.
The analysts expect for 2018 a net profit of 11,53 billion CHF. According to most of the analysts the company will have a profit per share for this book year of 5,11 CHF. So the price/earnings-ratio equals 15,07.
Novartis's market capitalization is around 178,51 billion CHF. The Novartis stock was the past 12 months quite unstable. Since last April the stock is 16 percent higher. This year the stock price moved between 64 and 86 CHF. Since 2008 the stock price is almost 107 percent higher.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.